By analyzing the relationship between clinical features and KRT80 expression, we found that KRT80 expression varied in different pathological stages, and KRT80 expression increased with increasing stage, which may predict that KRT80 is associated with tumor metastatic progression (Figure 10A). The gene discussed is KRT80; the disease is neoplasm.